Thermo Fisher Scientific Inc. (LON:0R0H)
501.42
-9.70 (-1.90%)
Mar 28, 2025, 8:09 PM BST
Thermo Fisher Scientific Revenue
In the year 2024, Thermo Fisher Scientific had annual revenue of $42.88B USD with 0.05% growth. Thermo Fisher Scientific had revenue of $11.40B in the quarter ending December 31, 2024, with 4.68% growth.
Revenue
$42.88B
Revenue Growth
+0.05%
P/S Ratio
n/a
Revenue / Employee
$343.03K
Employees
125,000
Market Cap
145.76B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Thermo Fisher Scientific News
- 4 days ago - Thermo Fisher Scientific and Chan Zuckerberg Institute for Advanced Biological Imaging Collaborate to Further Understanding of Human Cells - Business Wire
- 13 days ago - Thermo Fisher Scientific Introduces the Vulcan™ Automated Lab to Transform Semiconductor Analysis - Business Wire
- 17 days ago - Is the Market Bullish or Bearish on Thermo Fisher Scientific? - Benzinga
- 18 days ago - Market Whales and Their Recent Bets on TMO Options - Benzinga
- 20 days ago - Thermo Fisher Scientific: Not Living Up To Its Positioning - Seeking Alpha
- 23 days ago - Buy Two Ideal March 'Safer' Dividend Dogs Of 34 Barron's 2025 Pro-Picks - Seeking Alpha
- 24 days ago - Thermo Fisher Scientific: Strong Q4, Strategic M&A, And Poised For Growth In Life Sciences - Seeking Alpha
- 26 days ago - Invest with Confidence: Intrinsic Value Unveiled of Thermo Fisher Scientific Inc - GuruFocus